Condensed Statements of Stockholders' Deficit - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Beginning balance (in shares) at Dec. 31, 2023		118,210,315
Beginning balance at Dec. 31, 2023	$ (454,994)	$ 118	$ 1,149,170	$ (1,549,284)	$ 0	$ (54,998)
Increase (Decrease) in Stockholders' Equity
Vesting of restricted stock units and performance-based restricted stock units (in shares)		439,783
Vesting of restricted stock units and performance-based restricted stock units	1	$ 1
Stock-based compensation	3,235		3,235
Issuance of common stock from offering, net of issuance costs (in shares)		65,205,000
Issuance of common stock from offering, net of issuance costs	90,672	$ 65	90,607
Exercise of warrants (in shares)		4,000,000
Exercise of warrants	5,766	$ 4	5,762
Net income (loss)	61,022			61,022
Ending balance (in shares) at Mar. 31, 2024		187,855,098
Ending balance at Mar. 31, 2024	(294,298)	$ 188	1,248,774	(1,488,262)	0	(54,998)
Beginning balance (in shares) at Dec. 31, 2024		195,852,463
Beginning balance at Dec. 31, 2024	(388,722)	$ 196	1,267,109	(1,601,029)	0	(54,998)
Increase (Decrease) in Stockholders' Equity
Vesting of restricted stock units and performance-based restricted stock units (in shares)		461,779
Vesting of restricted stock units and performance-based restricted stock units	1	$ 1
Vesting of ESPP Shares (in shares)		346,129
Vesting of ESPP shares	500		500
Stock-based compensation	2,465		2,465
Net income (loss)	(40,455)			(40,455)
Ending balance (in shares) at Mar. 31, 2025		196,660,371
Ending balance at Mar. 31, 2025	$ (426,211)	$ 197	$ 1,270,074	$ (1,641,484)	$ 0	$ (54,998)